Bidding 23-25 Sep 2025, price band ₹65–70, lot 2000 shares.
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 29 Sep | ₹4 | ₹74 | 5.71% |
| 28 Sep | ₹4 | ₹74 | 5.71% |
| 27 Sep | ₹4 | ₹74 | 5.71% |
| 26 Sep | ₹4 | ₹74 | 5.71% |
| 25 Sep | ₹4 | ₹74 | 5.71% |
| 24 Sep | ₹4 | ₹74 | 5.71% |
| 23 Sep | ₹8 | ₹78 | 11.43% |
| 22 Sep | ₹7 | ₹77 | 10.00% |
| 21 Sep | ₹7 | ₹77 | 10.00% |
| 20 Sep | ₹7 | ₹77 | 10.00% |
| 19 Sep | ₹7 | ₹77 | 10.00% |
| 18 Sep | ₹7 | ₹77 | 10.00% |
| 17 Sep | ₹0 | ₹70 | 0.00% |
| 16 Sep | ₹0 | ₹70 | 0.00% |
| 15 Sep | ₹0 | ₹70 | 0.00% |
After allotment
| Category | Times | Est. Allotment Chances* |
|---|---|---|
| HNIs (Total) | 28.73🔥 | 3.5% |
| bHNI | 30.64🔥 | 3.3% |
| sHNI | 24.86🔥 | 4.0% |
| QIBs | 1.24 | - |
| Retail | 31.3🔥 | 3.2% |
| Total | 22.2🔥 | - |
*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.
Aptus Pharma is a Gujarat-based pharmaceutical company incorporated in 2010, engaged in marketing and distribution of finished pharmaceutical formulations. The company operates through a contract manufacturing model without owning manufacturing facilities, partnering with seven manufacturing units. Aptus offers a diverse range of pharmaceutical products across therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, and wellness products. Products are available in various dosage forms including tablets, capsules, syrups, injections, ointments, and drops.